Who owns ANEBULO PHARMACEUTICALS INC?
- Ticker: ANEB
- CUSIP Number: 034569103
Tip: Access positions for across all investors
Analyze quarterly positions in Anebulo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Anebulo Pharmaceuticals stock
Who bought or sold ANEBULO PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| 22NW | 16M | $39M | 0% | Sep 2025 |
|
| Nantahala Capital Management | 3.0M | $7.6M | 0% | Sep 2025 |
|
| Mangrove Partners | 2.5M | $6.3M | 0% | Sep 2025 |
|
| Morgan Stanley | 399k | $575k | 100% | Jun 2025 |
|
| Vanguard Group | 307k | $766k | 42% | Sep 2025 |
|
| Geode Capital Management | 174k | $436k | -15% | Sep 2025 |
|
| Ikarian Capital | 158k | $394k | 0% | Sep 2025 |
|
| Renaissance Technologies | 29k | $71k | 100% | Sep 2025 |
|
| Northern Trust | 24k | $61k | 100% | Sep 2025 |
|
| BlackRock | 24k | $60k | 40% | Sep 2025 |
|
| Rangeley Capital | 20k | $50k | 100% | Sep 2025 |
|
| XTX Topco | 19k | $48k | 100% | Sep 2025 |
|
| Boothbay Fund Management | 19k | $47k | 0% | Sep 2025 |
|
| State Street Corporation | 13k | $32k | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 2.1k | $5.3k | 26625% | Sep 2025 |
|
| Tower Research Capital | 1.8k | $4.4k | -46% | Sep 2025 |
|
| Barclays | 399.00 | $998.018700 | 100% | Sep 2025 |
|
| UBS Group | 220.00 | $550.000000 | 139% | Sep 2025 |
|
Who sold out of Anebulo Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| LVW Advisors | Jun 2025 | 350k | $503k |
| Millennium Management | Jun 2025 | 154k | $222k |
| Goldman Sachs Group | Mar 2025 | 48k | $62k |
| Citadel Advisors | Jun 2025 | 25k | $36k |
| Pnc Financial Services | Jun 2025 | 1.5k | $2.2k |